REVG - REV Group, Inc.
NYSE
->
Industrials
->
Farm & Heavy Construction Machinery
Brookfield,
United States
Type: Equity
REVG price evolution
REVG
| (in millions $) | 1 May 2024 | 1 Dec 2023 | 31 Aug 2023 | 30 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $87.9 | $21.3 | $11 | |
| Short term investments | ||||
| Net receivables | $223.5 | $226.5 | $210.6 | $239.5 |
| Inventory | $650.4 | $657.7 | $644 | $654.4 |
| Total current assets | $988.6 | $933.2 | $907 | $924.4 |
| Long term investments | ||||
| Property, plant & equipment | $188.1 | $196.5 | $190.6 | $184.9 |
| Goodwill & intangible assets | $237.7 | $273 | $273.5 | |
| Total noncurrent assets | $432.5 | $477.2 | $472.5 | |
| Total investments | ||||
| Total assets | $1421.1 | $1410.4 | $1379.5 | $1392.5 |
| Current liabilities | ||||
| Accounts payable | $165 | $208.3 | $192.7 | $185.7 |
| Deferred revenue | ||||
| Short long term debt | $7.2 | $7.4 | $7.8 | |
| Total current liabilities | $733.3 | $557.2 | $548.3 | $535.5 |
| Long term debt | $150 | $179 | $230 | |
| Total noncurrent liabilities | $191.7 | $355.2 | $362.6 | |
| Total debt | $35.6 | $187.4 | $217.2 | |
| Total liabilities | $925 | $912.4 | $910.9 | $939.2 |
| Shareholders' equity | ||||
| Retained earnings | $53 | $52.7 | $26 | $14.1 |
| Other shareholder equity | $0.2 | -$0.2 | -$0.2 | |
| Total shareholder equity | $496.1 | $498 | $468.6 | |
| (in millions $) | 31 Dec 2023 | 1 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $21.3 | $20.4 | $13.3 | $11.4 |
| Short term investments | ||||
| Net receivables | $226.5 | $215 | $213.3 | $229.3 |
| Inventory | $657.7 | $629.5 | $481.7 | $537.2 |
| Total current assets | $933.2 | $888.4 | $761 | $812 |
| Long term investments | ||||
| Property, plant & equipment | $196.5 | $169.1 | $176.7 | $191.6 |
| Goodwill & intangible assets | $273 | $276.5 | $283.6 | $293.4 |
| Total noncurrent assets | $477.2 | $456.2 | $477.3 | $500.3 |
| Total investments | ||||
| Total assets | $1410.4 | $1344.6 | $1238.3 | $1312.3 |
| Current liabilities | ||||
| Accounts payable | $208.3 | $163.9 | $116.2 | $169.5 |
| Deferred revenue | ||||
| Short long term debt | $7.4 | $6.1 | $7.1 | $10.1 |
| Total current liabilities | $557.2 | $527.4 | $437 | $447.3 |
| Long term debt | $180 | $230 | $227.8 | $357.4 |
| Total noncurrent liabilities | $355.2 | $360.9 | $282.5 | $392.7 |
| Total debt | $187.4 | $250.3 | $234.9 | $367.5 |
| Total liabilities | $912.4 | $888.3 | $719.5 | $840 |
| Shareholders' equity | ||||
| Retained earnings | $52.7 | $19.5 | $16.7 | -$21.1 |
| Other shareholder equity | $0.2 | $0.3 | -$0.1 | -$2.8 |
| Total shareholder equity | $498 | $456.3 | $518.8 | $472.3 |
| (in millions $) | 1 May 2024 | 1 Dec 2023 | 31 Aug 2023 | 30 May 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $693.3 | $680 | $681.2 | |
| Cost of revenue | ||||
| Gross Profit | $95.5 | $80.2 | $82.5 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $50.4 | $54.5 | $53.5 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $8.7 | $3.5 | $5.8 | |
| Interest expense | -$6.7 | -$7.3 | -$7.9 | |
| Net income | ||||
| Net income | $29.7 | $14.9 | $14.2 | |
| Income (for common shares) | ||||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2638 | $2331.6 | $2380.8 | $2277.6 |
| Cost of revenue | $2321.9 | $2084.1 | $2089.8 | $2049.5 |
| Gross Profit | $316.1 | $247.5 | $291 | $228.1 |
| Operating activities | ||||
| Research & development | $4.2 | $4.4 | $5.8 | |
| Selling, general & administrative | $224 | $190 | $189 | $204.9 |
| Total operating expenses | $227.5 | $210.7 | $207.2 | $246 |
| Operating income | $88.6 | $36.8 | $83.8 | -$17.9 |
| Income from continuing operations | ||||
| EBIT | $86.8 | $36.7 | $73 | -$20.4 |
| Income tax expense | $12.9 | $4.6 | $11.3 | -$15.6 |
| Interest expense | $28.6 | $16.9 | $17.3 | $25.7 |
| Net income | ||||
| Net income | $45.3 | $15.2 | $44.4 | -$30.5 |
| Income (for common shares) | $45.3 | $15.2 | $44.4 | -$30.5 |
| (in millions $) | 2 Mar 2024 | 1 Dec 2023 | 31 Aug 2023 | 30 May 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $297.7 | -$29.9 | -$18 | -$8.9 |
| Financing activities | ||||
| Dividends paid | -$3.1 | -$12.1 | -$9.1 | -$6.1 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$161.4 | -$95.7 | -$64.8 | -$10.7 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $66.6 | $0.9 | -$9.4 | -$11.4 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $45.3 | $15.2 | $44.4 | -$30.5 |
| Operating activities | ||||
| Depreciation | $26.2 | $32.3 | $32 | $40.2 |
| Business acquisitions & disposals | $1.2 | $1.8 | $2 | $7.2 |
| Stock-based compensation | $14.4 | $8.7 | $7.8 | $7.8 |
| Total cash flows from operations | $126.5 | $91.6 | $158.3 | $55.7 |
| Investing activities | ||||
| Capital expenditures | -$31.1 | -$16.6 | -$12.2 | -$5.5 |
| Investments | ||||
| Total cash flows from investing | -$29.9 | -$14.8 | -$10.2 | $1.7 |
| Financing activities | ||||
| Dividends paid | -$12.1 | -$12.4 | -$6.6 | -$9.5 |
| Sale and purchase of stock | $0.1 | -$69.7 | -$1.9 | $0.8 |
| Net borrowings | -$80 | $15 | -$135.4 | -$39.4 |
| Total cash flows from financing | -$95.7 | -$69.7 | -$146.2 | -$49.3 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.9 | $7.1 | $1.9 | $8.1 |
News
|
Forget the Mag 7, New Sectors and Stocks Are Starting to Win the Race
TheStreet.com
3 Apr 2024
|
|
Kintara to merge with TuHURA in all-stock deal (NASDAQ:KTRA)
Seeking Alpha
3 Apr 2024
|
|
Rocket Pharma stock gains as EU reviews gene therapy (NASDAQ:RCKT)
Seeking Alpha
2 Apr 2024
|
|
Frontier Airlines plans to take on legacy carriers in bid to boost profitability
Seeking Alpha
2 Apr 2024
|
|
REV Group (NYSE:REVG) Rating Lowered to Buy at StockNews.com
ETF DAILY NEWS
1 Apr 2024
|
|
TransMedics stock gain on bullish view at Piper Sandler
Seeking Alpha
28 Mar 2024
|
|
CervoMed stock soars on $149.4M private placement financing (NASDAQ:CRVO)
Seeking Alpha
28 Mar 2024
|
|
iBio stock climbs after AI drug discovery deal (NYSE:IBIO)
Seeking Alpha
27 Mar 2024
|
|
Movado expects higher spending on marketing will weigh on profits (NYSE:MOV)
Seeking Alpha
26 Mar 2024
|
|
Morgan Stanley defends bullish rating for Wayfair (W)
Seeking Alpha
25 Mar 2024
|
Fundamentals
| Market cap | $1.27B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 59.78M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.83 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.35 |
| Quick ratio | 0.46 |